BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 24, 2018
View Archived Issues
Gilteritinib granted orphan designation in Europe for treatment of AML
Read More
Tmunity announces closing of series A financing
Read More
Inhibitors of ATP1A4 may be novel agents for male contraception
Read More
Swissmedic accepts filing for edaravone as treatment for ALS
Read More
Skyhawk Therapeutics announces launch with USD 8 million in seed funding
Read More
Domainex wins award to develop screening method for GPCRs
Read More
Astellas completes Mitobridge acquisition
Read More
LifeArc enters partnership to identify new drug targets with machine-learning, bioinformatics
Read More
New mu-opioid receptor/CACNA2D1 ligands identified at Laboratorios del Dr. Esteve
Read More
Roche discovers novel HBsAg and HBV DNA production inhibitors
Read More
Glaceum describes novel glucose-lowering agents
Read More
FDA approves IND for Traumakine for ARDS
Read More
Evofem initiates phase IIb/III study of Amphora to prevent chlamydia and gonorrhea infections
Read More
University of California, Oakland patents HPV16 E5 gene-specific siRNA
Read More
Novel HPV vaccines synthesized at Deutsches Krebsforschungszentrum
Read More
Margetuximab awarded fast track designation for metastatic HER-positive breast cancer
Read More
Tie1 targeting shown to reduce tumor metastasis and growth
Read More
CARB-X seeks new accelerator organizations
Read More
NIH launches Somatic Cell Genome Editing program
Read More
Inclisiran receives FDA orphan designation for homozygous familial hypercholesterolemia
Read More
BioMarck Pharmaceuticals starts phase II trial of BIO-11006
Read More
Qiagen's ipsogen JAK2 assay cleared by FDA
Read More
EMA committee communicates negative trend vote to Puma for neratinib MAA
Read More
FDA clears BioAtla's IND for BA-3011
Read More